Citation: Cb. Eap et al., DETERMINATION OF CHLORZOXAZONE AND 6-HYDROXYCHLORZOXAZONE IN PLASMA BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY, Journal of chromatography B. Biomedical sciences and applications, 705(1), 1998, pp. 139-144
Citation: P. Baumann et al., ULTRARAPID METABOLISM OF CLOMIPRAMINE IN A THERAPY-RESISTANT DEPRESSIVE PATIENT, AS CONFIRMED BY CYP2 D6 GENOTYPING, Pharmacopsychiatry, 31(2), 1998, pp. 72-72
Authors:
EAP CB
LIMA CAD
MACCIARDI F
WOGGON B
POWELL K
BAUMANN P
Citation: Cb. Eap et al., STEADY-STATE CONCENTRATIONS OF THE ENANTIOMERS OF MIANSERIN AND DESMETHYLMIANSERIN IN POOR AND IN HOMOZYGOUS AND HETEROZYGOUS EXTENSIVE METABOLIZERS OF DEBRISOQUINE, Therapeutic drug monitoring, 20(1), 1998, pp. 7-13
Authors:
EAP CB
BOUCHOUX G
AMEY M
COCHARD N
SAVARY L
BAUMANN P
Citation: Cb. Eap et al., SIMULTANEOUS DETERMINATION OF HUMAN PLASMA-LEVELS OF CITALOPRAM, PAROXETINE, SERTRALINE, AND THEIR METABOLITES BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY, Journal of chromatographic science, 36(7), 1998, pp. 365-371
Authors:
EAP CB
SCHNYDER C
BESSON J
SAVARY L
BUCLIN T
Citation: Cb. Eap et al., INHIBITION OF CYP2E1 BY CHLORMETHIAZOLE AS MEASURED BY CHLORZOXAZONE PHARMACOKINETICS IN PATIENTS WITH ALCOHOLISM AND IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 64(1), 1998, pp. 52-57
Authors:
EAP CB
BUCLIN T
BUCHWALDER PA
GUTMANN N
BAUMANN P
Citation: Cb. Eap et al., MULTIPLE AND SIMULTANEOUS PHENOTYPING TESTS - BEWARE OF ASCORBIC-ACIDWHEN DETERMINING THE MEPHENYTOIN (S) (R) RATIO/, Clinica chimica acta, 271(1), 1998, pp. 105-107
Authors:
EAP CB
BERTSCHY G
BAUMANN P
FINKBEINER T
GASTPAR T
GASTPAR M
SCHERBAUM N
Citation: Cb. Eap et al., HIGH INTERINDIVIDUAL VARIABILITY OF METHADONE ENANTIOMER BLOOD-LEVELSTO DOSE RATIOS, Archives of general psychiatry, 55(1), 1998, pp. 89-90
Authors:
BONDOLFI G
DUFOUR H
PATRIS M
MAY JP
BILLETER U
EAP CB
BAUMANN P
Citation: G. Bondolfi et al., RISPERIDONE VERSUS CLOZAPINE IN TREATMENT-RESISTANT CHRONIC-SCHIZOPHRENIA - A RANDOMIZED DOUBLE-BLIND-STUDY, The American journal of psychiatry, 155(4), 1998, pp. 499-504
Citation: Cb. Eap et al., FLUVOXAMINE AND FLUOXETINE DO NOT INTERACT IN THE SAME WAY WITH THE METABOLISM OF THE ENANTIOMERS OF METHADONE, Journal of clinical psychopharmacology, 17(2), 1997, pp. 113-117
Citation: G. Bondolfi et al., GALACTORRHEA INDUCED BY A PHARMACODYNAMIC INTERACTION BETWEEN CITALOPRAM, ALPRAZOLAM AND TRAMADOL - A CASE-REPORT, Therapie, 52(1), 1997, pp. 76-77
Citation: Cb. Eap et al., DETERMINATION OF THE ENANTIOMERS OF MIANSERIN AND ITS METABOLITES IN PLASMA BY CAPILLARY ELECTROPHORESIS AFTER LIQUID-LIQUID-EXTRACTION ANDON-COLUMN SAMPLE PRECONCENTRATION, Journal of chromatographic science, 35(7), 1997, pp. 315-320
Citation: Cb. Eap et P. Baumann, ANALYTICAL METHODS FOR THE QUANTITATIVE-DETERMINATION OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS FOR THERAPEUTIC DRUG-MONITORING PURPOSES IN PATIENTS, Journal of chromatography B. Biomedical applications, 686(1), 1996, pp. 51-63
Citation: Cb. Eap et al., SIMULTANEOUS DETERMINATION OF PLASMA-LEVELS OF FLUVOXAMINE AND OF THEENANTIOMERS OF FLUOXETINE AND NORFLUOXETINE BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY, Journal of chromatography B. Biomedical applications, 682(2), 1996, pp. 265-272
Authors:
HERVE F
MILLOT MC
EAP CB
DUCHE JC
TILLEMENT JP
Citation: F. Herve et al., 2-STEP CHROMATOGRAPHIC PURIFICATION OF HUMAN PLASMA ALPHA(1)-ACID GLYCOPROTEIN - ITS APPLICATION TO THE PURIFICATION OF RARE PHENOTYPE SAMPLES OF THE PROTEIN AND THEIR STUDY BY CHROMATOGRAPHY ON IMMOBILIZED METAL CHELATE AFFINITY ADSORBENT, Journal of chromatography B. Biomedical applications, 678(1), 1996, pp. 1-14
Authors:
CONUS P
BONDOLFI C
EAP CB
MACCIARDI F
BAUMANN P
Citation: P. Conus et al., PHARMACOKINETIC FLUVOXAMINE - CLOMIPRAMINE INTERACTION WITH FAVORABLETHERAPEUTIC CONSEQUENCES IN THERAPY-RESISTANT DEPRESSIVE PATIENT, Pharmacopsychiatry, 29(3), 1996, pp. 108-110
Citation: G. Bertschy et al., FLUOXETINE ADDITION TO METHADONE IN ADDICTS - PHARMACOKINETIC ASPECTS, Therapeutic drug monitoring, 18(5), 1996, pp. 570-572
Authors:
EAP CB
FINKBEINER T
GASTPAR M
SCHERBAUM N
POWELL K
BAUMANN P
Citation: Cb. Eap et al., REPLACEMENT OF (R)-METHADONE BY A DOUBLE DOSE OF (R,S)-METHADONE IN ADDICTS - INTERINDIVIDUAL VARIABILITY OF THE (R) (S) RATIOS AND EVIDENCE OF ADAPTIVE-CHANGES IN METHADONE PHARMACOKINETICS/, European Journal of Clinical Pharmacology, 50(5), 1996, pp. 385-389
Authors:
EAP CB
GUENTERT TW
SCHAUBLINLOIDL M
STABL M
KOEB L
POWELL K
BAUMANN P
Citation: Cb. Eap et al., PLASMA-LEVELS OF THE ENANTIOMERS OF THIORIDAZINE, THIORIDAZINE 2-SULFOXIDE, THIORIDAZINE 2-SULFONE, AND THIORIDAZINE 5-SULFOXIDE IN POOR AND EXTENSIVE METABOLIZERS OF DEXTROMETHORPHAN AND MEPHENYTOIN, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 322-331
Citation: Cb. Eap et al., DETERMINATION OF THE ENANTIOMERS OF THIORIDAZINE, THIORIDAZINE 2-SULFONE, AND OF THE ISOMERIC PAIRS OF THIORIDAZINE 2-SULFOXIDE AND THIORIDAZINE 5-SULFOXIDE IN HUMAN PLASMA, Journal of chromatography B. Biomedical applications, 669(2), 1995, pp. 271-279
Citation: Cb. Eap et al., DETERMINATION OF TRIMIPRAMINE AND ITS DEMETHYLATED AND HYDROXYLATED METABOLITES IN PLASMA BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY, Journal of chromatography B. Biomedical applications, 652(1), 1994, pp. 97-103
Authors:
SEIFRITZ E
HOLSBOERTRACHSLER E
HEMMETER U
EAP CB
BAUMANN P
Citation: E. Seifritz et al., INCREASED TRIMIPRAMINE PLASMA-LEVELS DURING FLUVOXAMINE COMEDICATION, European neuropsychopharmacology, 4(1), 1994, pp. 15-20
Authors:
EAP CB
POWELL K
CAMPUSSOUCHE D
MONNEY C
BAETTIG D
TAESCHNER W
BAUMANN P
Citation: Cb. Eap et al., DETERMINATION OF THE ENANTIOMERS OF MIANSERIN, DESMETHYLMIANSERIN, AND 8-HYDROXYMIANSERIN IN THE PLASMA AND URINE OF MIANSERIN-TREATED PATIENTS, Chirality, 6(7), 1994, pp. 555-563
Authors:
BAUMANN P
HATZINGER M
HEMMETER U
SEIFRITZ E
EAP CB
HOLSBOER E
Citation: P. Baumann et al., INFLUENCE OF AMESERGIDE TREATMENT ON THE DEXTROMETHORPHAN TEST, British journal of clinical pharmacology, 38(2), 1994, pp. 151-152
Citation: G. Bertschy et al., PROBABLE METABOLIC INTERACTION BETWEEN METHADONE AND FLUVOXAMINE IN ADDICT PATIENTS, Therapeutic drug monitoring, 16(1), 1994, pp. 42-45
Citation: Cb. Eap et al., ARTIFACTS IN THE ANALYSIS OF THIORIDAZINE AND OTHER NEUROLEPTICS, Journal of pharmaceutical and biomedical analysis, 11(6), 1993, pp. 451-457